Have you had your cholesterol levels checked lately? High cholesterol is a
major risk factor for cardiovascular disease, which can lead to a heart attack
or stroke. Cardiovascular disease kills more men and women each year than any
other illness.
High blood cholesterol has no warning signs. People diagnosed with high cholesterol
often feel fine and therefore may not take their condition seriously.
Have your cholesterol levels checked regularly. If your level is high, there
are a lot of steps you can take to lower it.
References
AHA/AAP Policy Statement. Dietary recommendations for children and adolescents:
a guide for practitioners. Pediatrics. 2006 Feb;117(2):544-559.
Ansell BJ and Walters DD. Reassessment of national cholesterol education
program adult treatment panel III guidelines: one year later. American
Journal of Cardiology. 2002 Feb;90:524-525.
Eaton CB. Hyperlipidemia. Prim Care Clin Office Pract. 2005;32:1027-1055.
Grundy SM, et al. Implications of recent clinical trials for the national
cholesterol education program adult treatment panel III guidelines. Circulation.
2004 July;110:227-239.
Haines CA, et al. Assessment and management of lipid disorders in men. Prim
Care Office Pract. 2006;33:93-114.
Krauss RM and Siri PW. Metabolic abnormalities: triglyceride and low-density
lipoprotein. Endocrinol Metab Clin N Am. 2003;33:405-415.
Mosca L, Banka CL, Benjamin EJ, et al. Evidence-Based Guidelines for Cardiovascular
Disease Prevention in Women: 2007 Update. Circulation. 2007; Published online
before print February 19, 2007.
Rosenson RS. Evidence-based clinical practice: lowering LDL cholesterol
reduces risk of ischemic heart disease events. Evidence-based Healthcare:
A Scientific Approach to Health Policy. 2004 March;8(1).
The third report of the National Cholesterol Education Program (NCEP)
expert panel on detection, evaluation, and treatment of high blood cholesterol
in adults (Adult Panel III). Rockville, MD. National Heart, Lung,
and Blood Institute, US Dept of Health and Human Services; 2002. NIH publications
02-5215.
Vega GL. Management of atherogenic dyslipidemia of the metabolic syndrome:
evolving rationale for combined drug therapy. Endocrinol Metab Clin N
Am. 2004;33:525-544.